Streptococcus mutans has been identified as the most important etiological agent of dental caries (reviewed in references 9 and 16). Immunizations of rats and monkeys that result in increased salivary immunoglobulin A (IgA) specific for S. mutans can inhibit the colonization of teeth by these bacteria and reduce the incidence of dental caries (5, 13, 17, 28) . Therefore, it has been suggested that development of an S. mutans vaccine may be of value in controlling dental caries in humans. Yet, because dental caries is not a life-threatening disease, S. mutans antigens that exert adverse side effects are unacceptable vaccine components (16) .
Surface components of S. mutans have been shown to bind selectively glycoproteins of human saliva (8, 15, 20, 24) and cardiac antigens of Todd-Hewitt broth (25) . Crude extracts of a number of S. mutans serotypes contain antigens that bind in vitro to components of cardiac and skeletal muscle (26) . Recently, it has been shown that rabbits immunized with S. mutans strains KIR and MT703 develop kidney disease that exhibits many characteristics of streptococcusassociated nephritides (SAN) in humans (27) . This study was undertaken to identify the components of S. mutans that bind to heart and kidney tissues in vitro and to kidney tissue in vivo using an indirect radioimmunoassay and immunoblotting (Western blotting).
MATERIALS AND METHODS
Bacteria and cultural conditions. S. mutans strains AHT (serotype a), BHT (serotype b), 10449 (serotype c), KIR (serotype dig), MT703 (serotype e), and OMZ175 (serotype f) were grown on a dialysate of tryptic soy broth supplemented with 0.1% yeast extract (Difco Laboratories, Detroit, Mich.) and on chemically defined medium (31) . All cultures (1 liter of medium in a 2-liter Erlenmeyer flask) were incubated at 37°C and mixed at 25 rpm on a gyratory shaker * (New Brunswick Scientific Co., New Brunswick, N.J.). Growth was followed turbidimetrically at 600 nm with a Bausch & Lomb Spectronic 20 spectrophotometer. Cultures with optical densities of 0.8 to 1.2 (late-logarithmic to earlystationary phases of growth) were harvested by centrifugation at 10 ,000 x g for 15 min at 4°C. The cells were then washed twice with phosphate-buffered saline (PBS; 0.01 M NaH2PO4-Na2HPO4, pH 7.2, containing 0.15 M NaCl).
Immunization. Bacteria grown in the complex culture medium were disrupted by shaking with glass beads in a Braun cell homogenizer (Bronwill Scientific Inc., Rochester, N.Y.) at 4°C as described by Bleiweis et al. (2) . The vaccine of disrupted bacteria was heated at 70°C for 30 min, adjusted to 10 mg of protein per ml in PBS and stored at -20°C. New Zealand white rabbits were immunized with the sterile preparations of disrupted streptococci by intravenous injection three times a week as previously described (27) . The antisera used in this study were obtained 8 to 24 weeks after the start of the immunization regimen, a period in which many rabbits developed symptoms of nephritis (27) . The rabbits were test-bled every 4 weeks. Antibody titers to intact S. mutans were determined by indirect immunofluorescence assay to be between 640 and 2,560.
Extraction of bacteria. Intact cells were extracted sequentially with acetone, chloroform-methanol (2:1), and amnmonium hydroxide at pH 10 as previously described (23) . Lyophilized extracts were dissolved at 5 mg (dry weight) per ml of PBS for tissue-binding experiments.
Immunofluorescence. Antigens in S. mutans extracts were tested for their abilities to bind to 4-,um-thick cryostat-cut tissue sections of cynomolgus monkey (Macacafascicularis) heart and kidney (23, 26) . Briefly, tissue sections were incubated with the bacterial extract (5 mg [dry weight]/ml) for 30 min and washed with PBS for 15 min. Tissue-bound antigens were detected by indirect immunofluorescence (IIF) assay with rabbit antiserum elicited by immunization with the homologous bacterium and fluorescein isothiocyanate (FITC)-labeled goat anti-rabbit IgG as previously de-scribed (26) . Normal rabbit serum obtained before immunization and anti-S. muitans serum were incubated with both untreated, native tissue and tissue that was pretreated with bacterial antigens.
The components present in immune deposits within the tissues of immunized rabbits were identified by direct immunofluorescence as previously described (27) , using FITClabeled goat anti-rabbit IgG, IgM, IgA, and C3 (Cappel Laboratories Inc., West Chester, Pa.). Sections of tissues obtained from immunized rabbits were also examined by direct immunofluorescence for the presence of S. muitans antigens by using chicken anti-S. miitans antibodies that were conjugated with FITC by the procedures of Nairn (19) . This latter antiserum was elicited in chickens by injection of disrupted S. mnltans cells mixed with an equal volume of complete Freund adjuvant (GIBCO Laboratories, Grand Island, N.Y.). The chickens received 1 mg of protein in each footpad at 2-week intervals. The animals were exsanguinated after 8 weeks.
Radioiodination of protein A. Protein A (Pharmacia Fine Chemicals, Piscataway, N.J.) was radioiodinated by the chloramine-T procedure of Hunter (12) . The specific radioactivity of the '25I-protein A preparations ranged from 10,000 to 16,000 cpm/ng.
Tissue homogenization. Five grams each of monkey and rabbit heart and kidney tissues were cut into roughly 2-mm2 sections with razor blades and washed five times with 50 ml of ice-cold PBS to remove blood components. The fragments were suspended in 20 ml of PBS containing 2 mM phenylmethylsulfonyl fluoride and 0.05% sodium azide and homogenized at 4°C. After removing clumps of connective tissue by filtration through cotton gauze, each suspension was adjusted with PBS to 10 mg of protein per ml and stored at -70°C.
Indirect radioimmunoassay. Homogenized monkey and rabbit tissue was fixed to enzyme-linked immunosorbent assay plates (Immulon; Dynatech Laboratories, Alexandria, Va.) and washed with PBS-1% bovine serum albumin (BSA) as previously described (27) Fig. 1 and 2) .
Identification of tissue-bound streptococcal antigens. S. mutan MT703 was selected for these experiments because its tissue-binding antigens reacted strongly with antiserum in -TIX-'-_h;' j=E;;;4' ,2 -IIF assays, and administration of disrupted cell vaccines 600Xh W$Sitl!l; Ahl-t0 linduced severe glomerulonephritis in rabbits (27) . Binding of streptococcal antigens to monkey tissue in vitro was determined by radioimmunoassay (Fig. 3) since the antiserum did not react with tissue sections that were not pretreated with the extract (Fig. 1A) . Binding of S. mutans antigens to kidney sections is shown in Fig. 2 components stained by Coomassie blue in polyacrylamide gels, 11 reacted with antiserum to S. mutans after transfer to nitrocellulose paper (Fig. 4) ; none of the bands bound antibodies from a similarly diluted serum obtained from the rabbit before immunization. Extracts of monkey and rabbit heart and kidney tissue that had been pretreated with S. mutans extract showed two common antigenic bands (65,000 and 35,000 Mr). Monkey heart contained additional bacterial bands with apparent molecular weights of 90,000 and 120,000. The rabbit and monkey kidneys also bound smaller amounts of a bacterial antigen(s) of ca. 24,000 Mr. The antiserum to S. mutans did not react with SDS extracts of saline-treated control tissues under these conditions, proving that the antibodies were binding to bacterial antigens and not to tissue components.
Binding of streptococcal antigens in vivo. Rabbits injected intravenously with disrupted S. mutans vaccines were reported previously to develop extensive histopathological changes in the kidneys (27) . Microscopic examination of direct immunofluorescence-stained kidney sections obtained from rabbits during periods of proteinuria revealed immune deposits of C3, IgG, IgM, or IgA in the glomeruli. The IgGspecific strains showed smooth ribbon-like patterns along the GBM and granular deposits in the mesangium and on some sections of the GBM (Fig. 5) . Seven of 10 rabbits also contained streptococcal antigens in some glomeruli (Fig. 6) ; the intensity of the direct immunofluorescence with FITCchicken antibodies to S. mutans was greatest on kidneys I-O obtained during early disease, 8 to 12 weeks after the first injection of vaccine. The intensity and diffuse distribution of the IIF stain made identification of the sites of antigen deposition within the glomerulus difficult to determine (Fig.  6) . To identify the accumulated bacterial components, nephritic kidneys were extracted with SDS and analyzed by immunoblotting with rabbit anti-S. mutans MT703 serum; however, bacterial antigens were obscured by a variety of protein A-binding substances, presumably IgG and its degradation products, that were smeared throughout the polyacrylamide gel. Alternatively, the IgG contained in the immune complexes within the kidney tissue was dissociated and extracted by citrate buffer (pH 3.2). The eluted rabbit antibodies were reacted with nitrocellulose blots of SDS-PAGE-separated S. mutans antigens (Fig. 7) . Four bands, with apparent molecular weights of 65,000, 50,000, 35,000, and 24,000, were detected. Most of these corresponded to the bacterial antigens that bound to kidney and heart tissue in vitro (Fig. 4) . Comparison of this immunoblot with that of S. mutans extract and serum obtained from the animal at sacrifice showed that a number of major serum antibodies were absent in the kidney extract. This indicates that the eluted antibodies were bound to kidney tissue via tissuebound S. mutans antigens and were not free serum antibodies. DISCUSSION
The immunofluorescence staining of tissues treated with extracted components of S. mutans shows that this oral bacterium contains antigens that can bind directly to capillary walls and sarcolemmal sheaths of cardiac muscle and to basement membranes of kidney. Absorption of extracts of S. mutans MT703 with homogenized monkey and rabbit heart and kidney removed a number of bacterial antigens that were subsequently recovered and identified by immunoblotting techniques. Rabbit and monkey heart and kidney bound S. mutans antigens of 35,000 and 65,000 Mr. Rabbit and monkey kidneys also bound an antigen of approximately 24,000 Mr and monkey heart bound antigens with 90,000 and (27) has many histopathological and immunopathological similarities with streptococcus-associated nephritides in humans. In both diseases there is diffuse involvement of glomeruli marked by endotheliomesangial proliferation, infiltration by polymorphonuclear cells, and deposition of electron-dense "humps" on the basement membrane (18, 27) . These deposits contain predominantly complement component C3 and IgG; streptococcal antigens are also deposited early in the disease process (27) . Although SAN is well documented, the precise mechanism of tissue injury is unknown. Three mechanisms have been proposed to explain the pathogenesis of SAN: (i) direct tissue toxicity of the bound streptococcal components;. (ii) immune reactions with antigens in situ, including tissue-bound streptococcal antigens, cross-reacting renal antigens, and altered renal antigens; and (iii) deposition of circulating immune complexes.
The best characterized heart-and kidney-binding component of streptococci is lipoteichoic acid (LTA) (4, 14, 21, 29 Sera of rabbits immunized with S. mutans have been reported to contain antibodies that bind to normal heart and kidney tissue components in vitro (6, 11, 27, 30 Fig. 2 ). Most frequently, IgG is accumulated in nephritic kidneys in a granular pattern on the GBM (Fig. 5) , which may reflect the deposition of circulating immune complexes or in situ immune complex formation (27) . Direct immunofluorescence staining of S. mutans antigens in nephritic glomeruli showed both granular and linear patterns, which substantiates results published by Andres et al. (1) and Fillit et al. (7) showing streptococcal antigens in diseased glomeruli of human kidney. The antibodies specific for S. mutans antigens appear to contribute more to the formation of immune complexes in the rabbit kidney than the crossreactive antibodies, because antibodies eluted from nephritic kidney bound readily to S. mutans components in immunoblots (Fig. 7) but only weakly to extracted components of rabbit kidneys (unpublished data). The manner and sequence in which the reactants accumulate in tissues may be best resolved by organ perfusions with preparations of S. mutans antigens followed by antiserum or with mixtures of serum and antigens.
Because of the tissue-binding properties of the 65,000 and 35,000 Mr S. mutans components, it is tempting to propose that in situ immune complex formation is most important in initiating glomerular injury. However, a prominent role for circulating immune complexes in this disease cannot be excluded. Immune complexes have been detected in the serum of some rabbits, although they appeared only several hours after intravenous injections of the S. mutans preparation (27) . These immune complexes may ultimately localize in vessels and glomeruli, causing vasculitis and glomerulonephritis. The attachment of immune complexes to tissue may be mediated by the tissue-binding components of S. mutans or by a physical entrapment mechanism. The pathogenetic potential of circulating immune complexes is exemplified by acute serum sickness in rabbits, an experimental animal model that has some resemblance to SAN of humans (18) . However, some aspects of acute serum sickness differ from those of SAN. The prominent polymorphonuclear leukocyte infiltration of the glomerulus in SAN is generally absent in acute serum sickness.
The nature of the immunopathology, serology and microbiology of S. mutans-induced nephritis in rabbits indicates that this is an appropriate and reproducible animal model for studying streptococcus-associated kidney diseases. Attempts to develop a reproducible animal model with group A streptococci have, up to now, been unsuccessful (18) . With respect to prospective dental caries vaccines, we recommend that S. mutans antigens be purified to homogeneity and tested for tissue-binding activities as well as immunological cross-reactivities with heart and kidney components before use in humans. The desired vaccine antigen should not exert any deleterious effects on the host but must stimulate production of salivary immunoglobulins that will bind to the surface of S. mutans cells and inhibit the formation of dental caries. 
